Adjunct low-dose ketamine infusion vs standard of care in mechanically ventilated critically ill patients at a Tertiary Saudi Hospital (ATTAINMENT Trial): study protocol for a randomized, prospective, pilot, feasibility trial
- PMID: 32197636
- PMCID: PMC7085173
- DOI: 10.1186/s13063-020-4216-4
Adjunct low-dose ketamine infusion vs standard of care in mechanically ventilated critically ill patients at a Tertiary Saudi Hospital (ATTAINMENT Trial): study protocol for a randomized, prospective, pilot, feasibility trial
Abstract
Background: A noticeable interest in ketamine infusion for sedation management has developed among critical care physicians for critically ill patients. The 2018 Pain, Agitation/sedation, Delirium, Immobility, and Sleep disruption guideline suggested low-dose ketamine infusion as an adjunct to opioid therapy to reduce opioid requirements in post-surgical patients in the intensive care unit (ICU). This was, however, rated as conditional due to the very low quality of evidence. Ketamine has favorable characteristics, making it an especially viable alternative for patients with respiratory and hemodynamic instability. The Analgo-sedative adjuncT keTAmine Infusion iN Mechanically vENTilated ICU patients (ATTAINMENT) trial aims to assess the effect and safety of adjunct low-dose continuous infusion of ketamine as an analgo-sedative compared to standard of care in critically ill patients on mechanical ventilation (MV) for ≥ 24 h.
Methods/design: This trial is a prospective, randomized, active controlled, open-label, pilot, feasibility study of adult ICU patients (> 14 years old) on MV. The study will take place in the adult ICUs in the King Faisal Specialist Hospital and Research Center (KFSH&RC), Riyadh, Saudi Arabia, and will enroll 80 patients. Patients will be randomized post-intubation into two groups: the intervention group will receive an adjunct low-dose continuous infusion of ketamine plus standard of care. Ketamine will be administered over a period of 48 h at a fixed infusion rate of 2 μg/kg/min (0.12 mg/kg/h) in the first 24 h followed by 1 μg/kg/min (0.06 mg/kg/h) in the second 24 h. The control group will receive standard of care in the ICU (propofol and/or fentanyl and/or midazolam) according to the KFSH&RC sedation and analgesia protocol as clinically appropriate. The primary outcome is MV duration until ICU discharge, death, extubation, or 28 days post-randomization, whichever comes first.
Discussion: The first patient was enrolled on 1 September 2019. As of 10 October 2019, a total of 16 patients had been enrolled. We expect to complete the recruitment by 31 December 2020. The findings of this pilot trial will likely justify further investigation for the role of adjunct low-dose ketamine infusion as an analgo-sedative agent in a larger, multicenter, randomized controlled trial.
Trial registration: ClinicalTrials.gov: NCT04075006. Registered on 30 August 2019. Current controlled trials: ISRCTN14730035. Registered on 3 February 2020.
Keywords: ATTAINMENT; Critically ill; Delirium; Fentanyl; Ketamine; Mechanical ventilation; Midazolam; Propofol; Sedation; Standard of care; Vasopressors.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Adjunctive ketamine for sedation in critically ill mechanically ventilated patients: an active-controlled, pilot, feasibility clinical trial.J Intensive Care. 2021 Aug 30;9(1):54. doi: 10.1186/s40560-021-00569-1. J Intensive Care. 2021. PMID: 34462007 Free PMC article.
-
Continuous Infusion Ketamine for Adjunctive Analgosedation in Mechanically Ventilated, Critically Ill Patients.Pharmacotherapy. 2019 Mar;39(3):288-296. doi: 10.1002/phar.2223. Pharmacotherapy. 2019. PMID: 30746728
-
A Non-Comparative Prospective Pilot Study of Ketamine for Sedation in Adult Septic Shock.Mil Med. 2018 Nov 1;183(11-12):e409-e413. doi: 10.1093/milmed/usy121. Mil Med. 2018. PMID: 29800375
-
Alpha-2 agonists for sedation of mechanically ventilated adults in intensive care units: a systematic review.Health Technol Assess. 2016 Mar;20(25):v-xx, 1-117. doi: 10.3310/hta20250. Health Technol Assess. 2016. PMID: 27035758 Free PMC article. Review.
-
Analgosedation: a paradigm shift in intensive care unit sedation practice.Ann Pharmacother. 2012 Apr;46(4):530-40. doi: 10.1345/aph.1Q525. Epub 2012 Apr 10. Ann Pharmacother. 2012. PMID: 22496477 Review.
Cited by
-
Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study.Saudi Pharm J. 2024 May;32(5):102061. doi: 10.1016/j.jsps.2024.102061. Epub 2024 Apr 3. Saudi Pharm J. 2024. PMID: 38596319 Free PMC article.
-
The impact of ketamine on outcomes in critically ill patients: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials.Acute Crit Care. 2024 Feb;39(1):34-46. doi: 10.4266/acc.2023.00829. Epub 2024 Feb 28. Acute Crit Care. 2024. PMID: 38476062 Free PMC article.
-
Ketamine Infusion for Sedation and Analgesia during Mechanical Ventilation in the ICU: A Multicenter Evaluation.Crit Care Res Pract. 2022 Nov 30;2022:9853344. doi: 10.1155/2022/9853344. eCollection 2022. Crit Care Res Pract. 2022. PMID: 36504505 Free PMC article.
-
Adjunctive ketamine for sedation in critically ill mechanically ventilated patients: an active-controlled, pilot, feasibility clinical trial.J Intensive Care. 2021 Aug 30;9(1):54. doi: 10.1186/s40560-021-00569-1. J Intensive Care. 2021. PMID: 34462007 Free PMC article.
References
-
- Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46:e825–e873. doi: 10.1097/CCM.0000000000003299. - DOI - PubMed
-
- Whitman CB, Rhodes HM, Tellor BR, Hampton NB. Continuous infusion ketamine for adjunctive sedation in medical intensive care unit patients: a case series. Enliven: J Anesthesiol Crit Care Med. 2015;2(5):1–5.
-
- Moitra VK, Patel MK, Darrah D, Moitra A, Wunsch H. Low-dose ketamine in chronic critical illness. J Intensive Care Med. 2015;31(3):1–5. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials